1. Home
  2. AAPG vs VC Comparison

AAPG vs VC Comparison

Compare AAPG & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • VC
  • Stock Information
  • Founded
  • AAPG 2009
  • VC 2000
  • Country
  • AAPG China
  • VC United States
  • Employees
  • AAPG N/A
  • VC N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • VC Auto Parts:O.E.M.
  • Sector
  • AAPG Health Care
  • VC Consumer Discretionary
  • Exchange
  • AAPG Nasdaq
  • VC Nasdaq
  • Market Cap
  • AAPG 3.6B
  • VC 3.2B
  • IPO Year
  • AAPG 2025
  • VC 2000
  • Fundamental
  • Price
  • AAPG $34.61
  • VC $107.06
  • Analyst Decision
  • AAPG Buy
  • VC Strong Buy
  • Analyst Count
  • AAPG 1
  • VC 13
  • Target Price
  • AAPG N/A
  • VC $127.75
  • AVG Volume (30 Days)
  • AAPG 7.0K
  • VC 478.8K
  • Earning Date
  • AAPG 11-19-2025
  • VC 10-23-2025
  • Dividend Yield
  • AAPG N/A
  • VC 1.02%
  • EPS Growth
  • AAPG N/A
  • VC N/A
  • EPS
  • AAPG N/A
  • VC 11.17
  • Revenue
  • AAPG $54,524,554.00
  • VC $3,759,000,000.00
  • Revenue This Year
  • AAPG N/A
  • VC $1.24
  • Revenue Next Year
  • AAPG $368.64
  • VC $3.47
  • P/E Ratio
  • AAPG N/A
  • VC $9.66
  • Revenue Growth
  • AAPG N/A
  • VC N/A
  • 52 Week Low
  • AAPG $16.50
  • VC $65.10
  • 52 Week High
  • AAPG $48.45
  • VC $129.10
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 39.44
  • VC 31.18
  • Support Level
  • AAPG $33.12
  • VC $112.99
  • Resistance Level
  • AAPG $35.49
  • VC $117.13
  • Average True Range (ATR)
  • AAPG 0.97
  • VC 3.57
  • MACD
  • AAPG -0.22
  • VC -0.60
  • Stochastic Oscillator
  • AAPG 20.89
  • VC 2.23

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

Share on Social Networks: